{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:34:53Z","timestamp":1757781293225},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CCDT"],"published-print":{"date-parts":[[2008,5,1]]},"DOI":"10.2174\/156800908784293596","type":"journal-article","created":{"date-parts":[[2008,5,6]],"date-time":"2008-05-06T00:59:15Z","timestamp":1210035555000},"page":"180-186","source":"Crossref","is-referenced-by-count":9,"title":["Genetically Modified Cellular Vaccines for Therapy of Human Papilloma Virus Type 16 (HPV 16)-Associated Tumours"],"prefix":"10.2174","volume":"8","author":[{"given":"J.","family":"Bubenik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Cancer Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/66881","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T09:16:34Z","timestamp":1448270194000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1568-0096&volume=8&issue=3&spage=180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,1]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/156800908784293596","relation":{},"ISSN":["1568-0096"],"issn-type":[{"value":"1568-0096","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5,1]]}}}